Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
New Orleans, LA
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative site
mi
from
Boston, MA
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
Ann Arbor, MI
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
Rochester, MN
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
Rochester, MN
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
Tupelo, MS
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
Tupelo, MS
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
Omaha, NE
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
Brick, NJ
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
Brick, NJ
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
Mineola, NY
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
Mineola, NY
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
Bismark, ND
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
Bismark, ND
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative Site
mi
from
Mt. Pleasant, SC
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative Site
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  6/17/2013
Novartis Investigative site
mi
from
Dallas, TX
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD
A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 6/17/2013
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients
Rehabilitation of IPF Patients: Effects of Exercise and Oxidant Stress
Status: Enrolling
Updated:  6/18/2013
VA Medical Center, Miami
mi
from
Miami, FL
Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients
Rehabilitation of IPF Patients: Effects of Exercise and Oxidant Stress
Status: Enrolling
Updated: 6/18/2013
VA Medical Center, Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 34
mi
from
Phoenix, AZ
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 34
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10163
mi
from
Costa Mesa, CA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10163
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Huntington Beach, CA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10242
mi
from
Rolling Hills Estates, CA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10242
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
San Diego, CA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10179
mi
from
San Jose, CA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10179
mi
from
San Jose, CA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 1315
mi
from
Centennial, CO
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 1315
mi
from
Centennial, CO
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10133
mi
from
Denver, CO
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10133
mi
from
Denver, CO
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10128
mi
from
Wheat Ridge, CO
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10128
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10153
mi
from
Aventura, FL
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10153
mi
from
Aventura, FL
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 1345
mi
from
Miami, FL
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 1345
mi
from
Miami, FL
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10064
mi
from
Ormond Beach, FL
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10064
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Savannah, GA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 11501
mi
from
Overland Park, KA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 11501
mi
from
Overland Park, KA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10073
mi
from
Wichita, KA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10073
mi
from
Wichita, KA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10158
mi
from
Bethesda, MD
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10158
mi
from
Bethesda, MD
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10138
mi
from
North Dartmouth, MA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10138
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10531
mi
from
Plymouth, MN
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10531
mi
from
Plymouth, MN
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
St. Louis, MO
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10642
mi
from
Bozeman, MT
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10642
mi
from
Bozeman, MT
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10105
mi
from
High Point, NC
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10105
mi
from
High Point, NC
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Raleigh, NC
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10522
mi
from
Canton, OH
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10522
mi
from
Canton, OH
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Cincinnati, OH
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Oklahoma City, OK
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Tulsa, OK
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10132
mi
from
Eugene, OR
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10132
mi
from
Eugene, OR
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Medford, OR
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Portland, OR
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 1366
mi
from
Charleston, SC
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 1366
mi
from
Charleston, SC
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10517
mi
from
Spartanburg, SC
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10517
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Dallas, TX
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10149
mi
from
New Braunfels, TX
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10149
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
San Antonio, TX
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
eRT Remote Health Monitoring
Feasibility and Cost Effectiveness of Physiological Monitoring at Home in COPD Patients
Status: Enrolling
Updated:  6/28/2013
UCLA David Geffen School of Medicine
mi
from
Los Angeles, CA
eRT Remote Health Monitoring
Feasibility and Cost Effectiveness of Physiological Monitoring at Home in COPD Patients
Status: Enrolling
Updated: 6/28/2013
UCLA David Geffen School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated:  6/28/2013
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated: 6/28/2013
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated:  6/28/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated: 6/28/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated:  6/28/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated: 6/28/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials